Stay updated on Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new Revision: v3.6.3 is shown, replacing the previous v3.6.2, indicating a small software update to the interface.SummaryDifference0.0%

- Check19 days agoChange DetectedA new version (v3.6.2) of the study record was added on 2026-06-23 with updated Study Status and Contacts/Locations. This version replaces the previous revision (v3.6.0).SummaryDifference0.2%

- Check34 days agoChange DetectedThe page adds an eligibility check ('Check who can join') and a 'Find Contact Information' option. The revision label updates from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer revision tag was updated from v3.5.4 to v3.5.5, indicating a newer software release. This change is a backend/version update and does not modify study content or user-visible data.SummaryDifference0.0%

- Check48 days agoChange DetectedA new version entry on 2026-05-26 adds updates to the Study Status and Contacts/Locations sections, signaling updated recruitment status and contact details for the trial.SummaryDifference0.2%

- Check55 days agoChange DetectedA new revision on 2026-05-18 adds Contacts/Locations and Study Status to the record history, indicating updated site information and recruitment status. The 2026-04-17 entry was removed from the history.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.